BiotechTube
Home/Pipeline/MBX‑SD‑202

MBX‑SD‑202

Acute Clostridioides difficile infection

Phase 1Completed

Key Facts

Indication
Acute Clostridioides difficile infection
Phase
Phase 1
Status
Completed
Company
MyBiotics

About MyBiotics

Israeli microbiome biotech delivering AI‑enhanced live bacterial therapeutics for gut‑related diseases.

View full company profile

Therapeutic Areas

Infectious DiseasesGastroenterologyOncologyWomen's Health

Other Acute Clostridioides difficile infection Drugs

DrugCompanyPhase
MBX‑SD‑201MyBioticsPhase 1